Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives cover art

Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives

Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives

Listen for free

View show details

About this listen

CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In this episode, we speak with Dr. Richard Maziarz and CAR T Nurse Coordinator Bashi Ratterree of Oregon Health & Science University (OHSU). Together, they explain how CAR T‑cell therapy works, who may be eligible, what patients can expect during treatment and recovery, and the promising advancements shaping the future of this innovative therapy. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode: CAR T-cell therapyClinical Trial Support CenterCAR T-Cell Therapy: A Path of Hope and Healing Video SeriesBloodline Breakthroughs: innovations and inspiration video podcast: CAR T-cell TherapyHematology Horizons vlog: CAR T-Cell Therapy and the Patient ExperienceCAR T-Cell Therapy: Side Effects video Additional Blood Cancer United Support Resources: Information Specialists Financial supportOnline ChatFree Nutrition ConsultationsFree telephone/web patient programs Free booklets Young Adult ResourcesSupport groups Caregiver support Caregiver WorkbookSurvivorship WorkbookAdvocacy and Public PolicyPatient CommunityMental Health Resources Episode supported by Bristol Myers Squibb; Johnson & Johnson & Legend Biotech; Kite, a Gilead Company; Novartis Pharmaceuticals Corporation. The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first appeared on The Bloodline with Blood Cancer United Podcast.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.